2022-03-012023-02-282023-02-28false10015064OPTICAL PHARM LTD2023-10-0947910iso4217:GBPxbrli:pure100150642022-03-01100150642023-02-28100150642022-03-012023-02-28100150642021-03-01100150642022-02-28100150642021-03-012022-02-2810015064bus:SmallEntities2022-03-012023-02-2810015064bus:AuditExempt-NoAccountantsReport2022-03-012023-02-2810015064bus:AbridgedAccounts2022-03-012023-02-2810015064bus:PrivateLimitedCompanyLtd2022-03-012023-02-2810015064core:WithinOneYear2023-02-2810015064core:AfterOneYear2023-02-2810015064core:WithinOneYear2022-02-2810015064core:AfterOneYear2022-02-2810015064core:ShareCapital2023-02-2810015064core:SharePremium2023-02-2810015064core:RevaluationReserve2023-02-2810015064core:OtherReservesSubtotal2023-02-2810015064core:RetainedEarningsAccumulatedLosses2023-02-2810015064core:ShareCapital2022-02-2810015064core:SharePremium2022-02-2810015064core:RevaluationReserve2022-02-2810015064core:OtherReservesSubtotal2022-02-2810015064core:RetainedEarningsAccumulatedLosses2022-02-2810015064core:LandBuildings2023-02-2810015064core:PlantMachinery2023-02-2810015064core:Vehicles2023-02-2810015064core:FurnitureFittings2023-02-2810015064core:OfficeEquipment2023-02-2810015064core:NetGoodwill2023-02-2810015064core:IntangibleAssetsOtherThanGoodwill2023-02-2810015064core:ListedExchangeTraded2023-02-2810015064core:UnlistedNon-exchangeTraded2023-02-2810015064core:LandBuildings2022-02-2810015064core:PlantMachinery2022-02-2810015064core:Vehicles2022-02-2810015064core:FurnitureFittings2022-02-2810015064core:OfficeEquipment2022-02-2810015064core:NetGoodwill2022-02-2810015064core:IntangibleAssetsOtherThanGoodwill2022-02-2810015064core:ListedExchangeTraded2022-02-2810015064core:UnlistedNon-exchangeTraded2022-02-2810015064core:LandBuildings2022-03-012023-02-2810015064core:PlantMachinery2022-03-012023-02-2810015064core:Vehicles2022-03-012023-02-2810015064core:FurnitureFittings2022-03-012023-02-2810015064core:OfficeEquipment2022-03-012023-02-2810015064core:NetGoodwill2022-03-012023-02-2810015064core:IntangibleAssetsOtherThanGoodwill2022-03-012023-02-2810015064core:ListedExchangeTraded2022-03-012023-02-2810015064core:UnlistedNon-exchangeTraded2022-03-012023-02-2810015064core:MoreThanFiveYears2022-03-012023-02-2810015064core:Non-currentFinancialInstruments2023-02-2810015064core:Non-currentFinancialInstruments2022-02-2810015064dpl:CostSales2022-03-012023-02-2810015064dpl:DistributionCosts2022-03-012023-02-2810015064dpl:AdministrativeExpenses2022-03-012023-02-2810015064core:LandBuildings2022-03-012023-02-2810015064core:PlantMachinery2022-03-012023-02-2810015064core:Vehicles2022-03-012023-02-2810015064core:FurnitureFittings2022-03-012023-02-2810015064core:OfficeEquipment2022-03-012023-02-2810015064core:NetGoodwill2022-03-012023-02-2810015064core:IntangibleAssetsOtherThanGoodwill2022-03-012023-02-2810015064dpl:GroupUndertakings2022-03-012023-02-2810015064dpl:ParticipatingInterests2022-03-012023-02-2810015064dpl:GroupUndertakingscore:ListedExchangeTraded2022-03-012023-02-2810015064core:ListedExchangeTraded2022-03-012023-02-2810015064dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-03-012023-02-2810015064core:UnlistedNon-exchangeTraded2022-03-012023-02-2810015064dpl:CostSales2021-03-012022-02-2810015064dpl:DistributionCosts2021-03-012022-02-2810015064dpl:AdministrativeExpenses2021-03-012022-02-2810015064core:LandBuildings2021-03-012022-02-2810015064core:PlantMachinery2021-03-012022-02-2810015064core:Vehicles2021-03-012022-02-2810015064core:FurnitureFittings2021-03-012022-02-2810015064core:OfficeEquipment2021-03-012022-02-2810015064core:NetGoodwill2021-03-012022-02-2810015064core:IntangibleAssetsOtherThanGoodwill2021-03-012022-02-2810015064dpl:GroupUndertakings2021-03-012022-02-2810015064dpl:ParticipatingInterests2021-03-012022-02-2810015064dpl:GroupUndertakingscore:ListedExchangeTraded2021-03-012022-02-2810015064core:ListedExchangeTraded2021-03-012022-02-2810015064dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-03-012022-02-2810015064core:UnlistedNon-exchangeTraded2021-03-012022-02-2810015064core:NetGoodwill2023-02-2810015064core:IntangibleAssetsOtherThanGoodwill2023-02-2810015064core:LandBuildings2023-02-2810015064core:PlantMachinery2023-02-2810015064core:Vehicles2023-02-2810015064core:FurnitureFittings2023-02-2810015064core:OfficeEquipment2023-02-2810015064core:AfterOneYear2023-02-2810015064core:WithinOneYear2023-02-2810015064core:ListedExchangeTraded2023-02-2810015064core:UnlistedNon-exchangeTraded2023-02-2810015064core:ShareCapital2023-02-2810015064core:SharePremium2023-02-2810015064core:RevaluationReserve2023-02-2810015064core:OtherReservesSubtotal2023-02-2810015064core:RetainedEarningsAccumulatedLosses2023-02-2810015064core:NetGoodwill2022-02-2810015064core:IntangibleAssetsOtherThanGoodwill2022-02-2810015064core:LandBuildings2022-02-2810015064core:PlantMachinery2022-02-2810015064core:Vehicles2022-02-2810015064core:FurnitureFittings2022-02-2810015064core:OfficeEquipment2022-02-2810015064core:AfterOneYear2022-02-2810015064core:WithinOneYear2022-02-2810015064core:ListedExchangeTraded2022-02-2810015064core:UnlistedNon-exchangeTraded2022-02-2810015064core:ShareCapital2022-02-2810015064core:SharePremium2022-02-2810015064core:RevaluationReserve2022-02-2810015064core:OtherReservesSubtotal2022-02-2810015064core:RetainedEarningsAccumulatedLosses2022-02-2810015064core:NetGoodwill2021-03-0110015064core:IntangibleAssetsOtherThanGoodwill2021-03-0110015064core:LandBuildings2021-03-0110015064core:PlantMachinery2021-03-0110015064core:Vehicles2021-03-0110015064core:FurnitureFittings2021-03-0110015064core:OfficeEquipment2021-03-0110015064core:AfterOneYear2021-03-0110015064core:WithinOneYear2021-03-0110015064core:ListedExchangeTraded2021-03-0110015064core:UnlistedNon-exchangeTraded2021-03-0110015064core:ShareCapital2021-03-0110015064core:SharePremium2021-03-0110015064core:RevaluationReserve2021-03-0110015064core:OtherReservesSubtotal2021-03-0110015064core:RetainedEarningsAccumulatedLosses2021-03-0110015064core:AfterOneYear2022-03-012023-02-2810015064core:WithinOneYear2022-03-012023-02-2810015064core:Non-currentFinancialInstrumentscore:CostValuation2022-03-012023-02-2810015064core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-03-012023-02-2810015064core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-03-012023-02-2810015064core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-03-012023-02-2810015064core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-03-012023-02-2810015064core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-03-012023-02-2810015064core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-03-012023-02-2810015064core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-03-012023-02-2810015064core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-03-012023-02-2810015064core:Non-currentFinancialInstrumentscore:CostValuation2023-02-2810015064core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-02-2810015064core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-02-2810015064core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-02-2810015064core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-02-2810015064core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-02-2810015064core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-02-2810015064core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-02-2810015064core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-02-2810015064core:Non-currentFinancialInstrumentscore:CostValuation2022-02-2810015064core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-02-2810015064core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-02-2810015064core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-02-2810015064core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-02-2810015064core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-02-2810015064core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-02-2810015064core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-02-2810015064core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-02-2810015064bus:Director12022-03-012023-02-28

OPTICAL PHARM LTD

Registered Number
10015064
(England and Wales)

Unaudited Financial Statements for the Year ended
28 February 2023

OPTICAL PHARM LTD
Company Information
for the year from 1 March 2022 to 28 February 2023

Director

Hardev Singh Bhopal

Registered Address

92c Boldmere Road
Birmingham
B73 5UB

Place of Business


Registered Number

10015064 (England and Wales)
OPTICAL PHARM LTD
Balance Sheet as at
28 February 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Tangible assets51,8972,655
1,8972,655
Current assets
Stocks60,69851,800
Debtors2,8941,555
Cash at bank and on hand5,00210,996
68,59464,351
Creditors amounts falling due within one year7(87,625)(101,819)
Net current assets (liabilities)(19,031)(37,468)
Total assets less current liabilities(17,134)(34,813)
Net assets(17,134)(34,813)
Capital and reserves
Called up share capital100100
Profit and loss account(17,234)(34,913)
Shareholders' funds(17,134)(34,813)
The financial statements were approved and authorised for issue by the Director on 9 October 2023, and are signed on its behalf by:
Hardev Singh Bhopal
Director
Registered Company No. 10015064
OPTICAL PHARM LTD
Notes to the Financial Statements
for the year ended 28 February 2023

1.Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
2.Compliance with applicable reporting framework
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
3.Accounting policies
Property, plant and equipment policy
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Straight line (years)
Fixtures and fittings15
Stocks policy
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
Revenue recognition policy
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign currency translation and operations policy
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
4.Employee information

20232022
Average number of employees during the year12
5.Property, plant and equipment

Total

£
Cost or valuation
At 01 March 225,056
At 28 February 235,056
Depreciation and impairment
At 01 March 222,400
Charge for year759
At 28 February 233,159
Net book value
At 28 February 231,897
At 28 February 222,655
6.Debtors within one year

2023

2022

££
Other debtors2,8941,555
Total2,8941,555
7.Creditors within one year

2023

2022

££
Trade creditors / trade payables2,0243,368
Taxation and social security19844
Other creditors85,40398,407
Total87,625101,819